CMP compumedics limited

News: CMP Compumedics Revises Revenue Guidance Upwards To More Than A$46M For Full Year Fy2024

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 29 (Reuters) - Compumedics Ltd (CMP) :

    • REVISES REVENUE GUIDANCE UPWARDS TO MORE THAN A$46M FOR FULL YEAR FY2024
    • EXPECTS EBITDA TO BE MORE THAN A$5.0M FOR FY
    • ACTIVELY WORKING TO RESTORE SUSTAINABLE PROFITABILITY OVER H2 FY24 AND INTO H1 FY25
    • HY REVENUES A$26.4 MILLION VERSUS A$19.2 MILLION
    • HY EBITDA PROFIT OF A$2.2 MILLION VERSUS LOSS OF A$4.8 MILLION
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $53.82M
Open High Low Value Volume
28.0¢ 28.0¢ 28.0¢ $410 1.464K

Buyers (Bids)

No. Vol. Price($)
2 27903 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 3793 1
View Market Depth
Last trade - 10.17am 18/07/2025 (20 minute delay) ?
CMP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.